Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

重组人凝血酶 - NMPA Drug Approval Details

Approvals/NMPA/Recombinant Human Thrombin

Approved

生物制品

Recombinant Human Thrombin

苏州泽璟生物制药股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 26, 2023
Approval ID: 8WEmEwrozMr
Company: 苏州泽璟生物制药股份有限公司
Type: 生物制品

Approval Details

Approval Id: 8WEmEwrozMr
Approval Number: 国药准字S20230073
Generic Name: 重组人凝血酶
Generic Name En: Recombinant Human Thrombin
Drug Type: 生物制品
Dosage Form: 涂剂
Strength: 5000 IU/支
Reg Date: 2023-12-26
Company Name: 苏州泽璟生物制药股份有限公司
Company Address: 江苏省昆山市玉山镇晨丰路209号
Production Company Name: 苏州泽璟生物制药股份有限公司
Production Company Address: 江苏省昆山市玉山镇元丰路168号
Company Detail Path: /organization/991b50aa2987da2e/suzhou-zelgen-biopharmaceuticals-co-ltd
Production Company Detail Path: /organization/991b50aa2987da2e/suzhou-zelgen-biopharmaceuticals-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 26, 2023

Approval ID

8WEmEwrozMr

Type

生物制品

Back to NMPA Approvals